Radiological Cardiothoracic Ratio as a Potential Marker of Left Ventricular Hypertrophy Assessed by Echocardiography

Krystian Truszkiewicz1, Piotr Macek2, Małgorzata Poręba3

  • 1Center for Diagnostic Imaging, University Clinical Hospital in Wroclaw, Wroclaw, Poland.

Insights

The cardiothoracic ratio (CTR) on chest X-rays can help detect left ventricular hypertrophy (LVH). A CTR cutoff of 0.49 shows high accuracy in identifying LVH, serving as a useful screening tool.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Left ventricular hypertrophy (LVH) is a significant cardiovascular risk factor.
  • Echocardiography is the gold standard for assessing LVH, but it is not always accessible.
  • Radiological assessment using the cardiothoracic ratio (CTR) is a widely available imaging technique.

Purpose of the Study:

  • To evaluate the utility of the cardiothoracic ratio (CTR) as a non-invasive marker for left ventricular hypertrophy (LVH).
  • To compare CTR measurements with echocardiographic findings in a cohort of patients.
  • To determine optimal CTR cut-off values for predicting different types of left ventricular geometry.

Main Methods:

  • Retrospective analysis of 96 patients undergoing both chest radiography (PA projection) and echocardiography.
  • Measurement of cardiothoracic ratio (CTR) from chest radiographs, with CTR > 0.50 indicating heart silhouette enlargement.
  • Assessment of left ventricular geometry by echocardiography: normal geometry (NG), concentric remodeling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH).

Main Results:

  • Patients with enlarged heart silhouettes (CTR > 0.50) showed significantly higher prevalence of LVH compared to those without.
  • A CTR threshold of > 0.49 demonstrated high sensitivity (93.3%) and specificity (82.7%) for detecting LVH, yielding an overall accuracy of 84.4%.
  • CTR > 0.49 accurately predicted CH (80.2% accuracy), while CTR > 0.52 was better for EH (71.9% accuracy), though CR prediction was less accurate.

Conclusions:

  • The cardiothoracic ratio (CTR) is a moderately effective radiological marker for left ventricular hypertrophy (LVH) when compared to echocardiographic criteria.
  • Establishing population-specific cut-off points for CTR is crucial for optimizing its diagnostic performance.
  • CTR can serve as a valuable, accessible screening tool for LVH, particularly in resource-limited settings.

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
297
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
51
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
50
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
23
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
34